DMAC

SEC source: 0001760123-26-000004 · form4-08122026_080836.xml · nonDerivative · entry 1

Pauls Dietrich John · CIK 0001760123 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,791

F1 · shares: The restricted stock units will vest in four equal installments, each on the first, second, third, and fourth anniversaries of the grant date, provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.

F2 · balance_after: Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.

SEC source: 0001643127-26-000002 · form4-06032026_090627.xml · derivative · entry 1

Krop Julie · CIK 0001643127 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,500

Underlying: Voting Common Shares · 67,500 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments.

SEC source: 0001490476-26-000002 · form4-06032026_090610.xml · derivative · entry 1

Kellen Scott · CIK 0001490476 · CFO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,000

Underlying: Voting Common Shares · 162,000 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments.

SEC source: 0001451038-26-000002 · form4-06032026_090650.xml · derivative · entry 1

Lewis Tanya · CIK 0001451038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,412

Underlying: Voting Common Shares · 40,412 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest in four equal quarterly installments.

SEC source: 0001759822-26-000004 · form4-06032026_090625.xml · derivative · entry 1

Giuffre Randall Michael · CIK 0001759822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,412

Underlying: Voting Common Shares · 40,412 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest in four equal quarterly installments.

SEC source: 0001341125-26-000002 · form4-06032026_090653.xml · derivative · entry 1

Kuntz Richard · CIK 0001341125 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,412

Underlying: Voting Common Shares · 40,412 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest in four equal quarterly installments.

SEC source: 0001376847-26-000002 · form4-06032026_090622.xml · derivative · entry 1

O'Connor Daniel J. · CIK 0001376847 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,412

Underlying: Voting Common Shares · 40,412 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest in four equal quarterly installments.

SEC source: 0001872863-26-000004 · form4-06032026_090620.xml · derivative · entry 1

Semba Charles Pauling · CIK 0001872863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,412

Underlying: Voting Common Shares · 40,412 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest in four equal quarterly installments.

SEC source: 0001759855-26-000004 · form4-06032026_090621.xml · derivative · entry 1

Parsons James T. · CIK 0001759855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,189

Underlying: Voting Common Shares · 51,189 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest in four substantially equal quarterly installments.

SEC source: 0001760123-26-000002 · form4-06032026_090640.xml · derivative · entry 1

Pauls Dietrich John · CIK 0001760123 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,000

Underlying: Voting Common Shares · 380,000 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments.

SEC source: 0001872863-26-000002 · form4-01062026_100121.xml · nonDerivative · entry 1

Semba Charles Pauling · CIK 0001872863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,963

F1 · shares: Shares are issuable upon settlement of restricted stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $28,250. The restricted stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026."

SEC source: 0001759855-26-000002 · form4-01062026_100130.xml · nonDerivative · entry 1

Parsons James T. · CIK 0001759855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,949

F1 · shares: Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $85,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.

SEC source: 0001759822-26-000002 · form4-01062026_100105.xml · nonDerivative · entry 1

Giuffre Randall Michael · CIK 0001759822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,587

F1 · shares: Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $52,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026.

SEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 7

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 8,825,742

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 6

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 8,752,643

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001759855-25-000006 · form4-11252025_091152.xml · derivative · entry 2

Parsons James T. · CIK 0001759855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 12,000 shares

Expires 2025-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents the conversion of the exercise price from CAD$ to US$ on the transaction date.

F2 · derivative.exercise_date: Fully vested.

SEC source: 0001759855-25-000006 · form4-11252025_091152.xml · nonDerivative · entry 1

Parsons James T. · CIK 0001759855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents the conversion of the exercise price from CAD$ to US$ on the transaction date.

SEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 5

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 8,712,390

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 4

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 8,503,518

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 3

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 8,375,092

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 2

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 8,134,740

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-119360 · tm2531638-1_4seq1.xml · nonDerivative · entry 1

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,951,858

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 9

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,764,465

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 8

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,713,693

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 7

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,654,045

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 6

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,315,780

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 5

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,255,992

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 4

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,207,820

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 3

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,136,713

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 2

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,128,480

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-087410 · tm2525163-2_4seq1.xml · nonDerivative · entry 1

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 7,058,066

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001643127-25-000006 · form4-11032025_091158.xml · derivative · entry 1

Krop Julie · CIK 0001643127 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2035-08-10

F1 · derivative.exercise_date: 112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.

SEC source: 0001104659-25-070920 · tm2521564-1_4seq1.xml · nonDerivative · entry 1

STAHLBERG JAN · CIK 0001983161 · 10% owner

TRILL AB · CIK 0001887436 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote 1

Disclosed balance after: 6,764,465

F1 · ownership.nature: These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.

SEC source: 0001104659-25-070900 · tm2521564-2_4seq1.xml · nonDerivative · entry 1

Von Koch Thomas · CIK 0001938915 · 10% owner

TomEnterprise AB · CIK 0001887435 · 10% owner

TomEnterprise Private AB · CIK 0001956782 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote 1

Disclosed balance after: 8,383,577

F1 · ownership.nature: These shares are owned directly by TomEnterprise Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares.

SEC source: 0001437749-25-023532 · rdgdoc.xml · nonDerivative · entry 1

JACINTO RICHARD II · CIK 0001196834 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Roth IRA

Disclosed balance after: 4,958,823

F1 · ownership.nature: These shares are held by NFS/FMTC Roth IRA FBO Richard Jacinto II, of which Richard Jacinto II is the beneficiary.

SEC source: 0001437749-25-019290 · rdgdoc.xml · derivative · entry 2

Kellen Scott · CIK 0001490476 · CFO & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Shares · 225,000 shares

Expires 2035-05-31

F1 · derivative.exercise_date: Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026.

SEC source: 0001437749-25-019292 · rdgdoc.xml · derivative · entry 2

Lewis Tanya · CIK 0001451038 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,162

Underlying: Common Shares · 32,162 shares

Expires 2035-05-31

F1 · derivative.exercise_date: Vests in four nearly equal quarterly installments over one year.

SEC source: 0001437749-25-019296 · rdgdoc.xml · derivative · entry 2

Wambeke David J. · CIK 0001971798 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Shares · 250,000 shares

Expires 2035-05-31

F1 · derivative.exercise_date: Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026.

SEC source: 0001437749-25-019295 · rdgdoc.xml · derivative · entry 2

Semba Charles Pauling · CIK 0001872863 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,162

Underlying: Common Shares · 32,162 shares

Expires 2035-05-31

F2 · derivative.exercise_date: Vests in four nearly equal quarterly installments over one year.

SEC source: 0001437749-25-019294 · rdgdoc.xml · derivative · entry 2

Pauls Dietrich John · CIK 0001760123 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Shares · 600,000 shares

Expires 2035-05-31

F2 · derivative.exercise_date: Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026.

SEC source: 0001437749-25-019293 · rdgdoc.xml · derivative · entry 2

Parsons James T. · CIK 0001759855 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,739

Underlying: Common Shares · 40,739 shares

Expires 2035-05-31

F2 · derivative.exercise_date: Vests in four nearly equal quarterly installments over one year.

SEC source: 0001437749-25-019291 · rdgdoc.xml · derivative · entry 2

Kuntz Richard · CIK 0001341125 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,162

Underlying: Common Shares · 32,162 shares

Expires 2035-05-31

F2 · derivative.exercise_date: Vests in four nearly equal quarterly installments over one year.

SEC source: 0001437749-25-019289 · rdgdoc.xml · derivative · entry 4

Giuffre Randall Michael · CIK 0001759822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,162

Underlying: Common Shares · 32,162 shares

Expires 2035-05-31

F3 · derivative.exercise_date: Vests in four nearly equal quarterly installments over one year.

SEC source: 0001760016-25-000004 · primary_doc.xml · derivative · entry 2

Pilnik Richard D. · CIK 0001760016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Voting Common Shares · 24,000 shares

Expires 2025-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025.

F3 · derivative.exercise_date: This option has fully vested.

SEC source: 0001760016-25-000004 · primary_doc.xml · nonDerivative · entry 1

Pilnik Richard D. · CIK 0001760016 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents an exercise price of $3.00 Canadian dollars, converted to U.S. dollars at an exchange rate of CAD$0.7032 to U.S. $1.00 on April 4, 2025.

F2 · balance_after: Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 139,954 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time.

SEC source: 0001235802-25-000012 · primary_doc.xml · derivative · entry 2

O'Connor Daniel J. · CIK 0001376847 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,242

Underlying: Common Stock · 64,242 shares

Expires 2035-02-19

F1 · derivative.exercise_date: Vests in 12 nearly equal quarterly installments over three years.

SEC source: 0001235802-25-000009 · primary_doc.xml · derivative · entry 6

Giuffre Randall Michael · CIK 0001759822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 5,000 shares

Expires 2026-11-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option has fully vested.

SEC source: 0001235802-25-000009 · primary_doc.xml · derivative · entry 5

Giuffre Randall Michael · CIK 0001759822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 12,000 shares

Expires 2025-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option has fully vested.

SEC source: 0001235802-25-000009 · primary_doc.xml · nonDerivative · entry 2

Giuffre Randall Michael · CIK 0001759822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,412

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually.

SEC source: 0001235802-25-000009 · primary_doc.xml · nonDerivative · entry 1

Giuffre Randall Michael · CIK 0001759822 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387,412

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually.